Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$57.2 - $74.41 $692,120 - $900,361
-12,100 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$57.05 - $95.75 $690,305 - $1.16 Million
12,100 New
12,100 $815,000
Q4 2019

Feb 14, 2020

SELL
$68.3 - $93.8 $227,643 - $312,635
-3,333 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$61.86 - $97.8 $206,179 - $325,967
3,333 New
3,333 $249,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.23B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Js Capital Management LLC Portfolio

Follow Js Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Js Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Js Capital Management LLC with notifications on news.